Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D
Author(s) -
Jan Rupp,
Werner Solbach,
Jens Gieffers
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm447
Subject(s) - moxifloxacin , serotype , quinolone , microbiology and biotechnology , rifampicin , biology , chlamydia trachomatis , chlamydiae , ciprofloxacin , dna gyrase , mutant , virology , antibiotics , gene , genetics , escherichia coli
Quinolone resistance of chlamydiae is supposed to be extremely rare. To assess the risk for the emergence of chlamydial quinolone resistance, we analysed the occurrence of resistant mutants in a quantitative perspective.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom